|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Combo: DNA & protein vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2010-10-04|
|Study Made Public:||2012-02-14|
Evaluation of gp41 MPER based liposomes in inducing neutralizing antibodies
CAVD 341 is an immunogenicity study of broadly neutralizing antibodies evaluating gp41 MPER based liposomes in inducing neutralizing antibodies.
Sign in to see full information about this study and to download study data.